Received Mar 26, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
low prevalence of measles seroprotection despite evidence of at least 2 childhood MMR vaccinations; This Literature (Spontaneous) report has been received from the authors of a published article and referred to an adult patient of unknown age and gender. The patient's concurrent condition included non-perinatally-acquired HIV (NPHIV). The patient's past and concomitant medications were not reported. On unknown dates, the patient were vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (MMR) powder and solvent for solution for injection, reconstituted in sterile diluent (Dose, dose number, route, anatomical location, Lot # and Expiration date were not reported) for prophylaxis The patient had no measles seroprotection despite evidence of at least 2 childhood MMR vaccinations (Vaccination failure) as shown on measles serology shown on quantitative IgG on an unknown date. Linked Case(s): Same Literature: US-009507513-2395110 Batch/Lot number is being requested and will be submitted if received
HIV infection
Sterile diluent
Test Name: measles serology quantitative IgG; Result Unstructured Data: No measles seroprotection